Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese

Qibin Qi, Jing Wang, Huaixing Li, Zhijie Yu, Xingwang Ye, Frank B. Hu, Oscar H. Franco, An Pan, Yong Liu, Xu Lin

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective: Resistin increases insulin resistance (IR) in mice. However, the role of resistin in human disease remains controversial. We aimed to assess plasma resistin levels and their associations with inflammatory and fibrinolytic markers, IR and metabolic syndrome (MetS) among Chinese. Design and methods: Plasma resistin was measured in a population-based cross-sectional survey of 3193 Chinese aged from 50 to 70 years in Beijing and Shanghai. Results: The median resistin concentration was 8.60 ng/ml (interquartile range, 5.78-14.00) among all participants, and it was higher in women than in men (P=0.008). Resistin was correlated weakly with body mass index, waist circumference, high-density lipoprotein (HDL) cholesterol (negatively), homeostatic model assessment of IR and tumor necrosis factor-α receptor 2 (TNFR2; r=0.04, 0.07, -0.09 and 0.06 respectively, all P <0.05), and more highly with C-reactive protein (CRP), interleukin (IL)6 and plasminogen activator inhibitor (PAI1 (r=0.12, 0.12 and 0.21 respectively, all P<0.001), but only HDL cholesterol, CRP, IL6, TNFR2, and PAI1 remained significantly associated with resistin in multiple regression analysis (all P <0.05). Furthermore, elevated resistin levels were associated with the higher prevalence of IR and MetS. However, the significant relationships disappeared after adjustment for inflammatory and fibrinolytic markers especially PAI1. Conclusions: This study suggests that resistin is more strongly associated with inflammatory and fibrinolytic markers than with obesity or IR status. The associations of resistin with IR and MetS could largely be explained by inflammatory and fibrinolytic markers especially PAI1 levels.

Original languageEnglish (US)
Pages (from-to)585-593
Number of pages9
JournalEuropean Journal of Endocrinology
Volume159
Issue number5
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Resistin
Insulin Resistance
Receptors, Tumor Necrosis Factor, Type II
C-Reactive Protein
HDL Cholesterol
Interleukin-6
Plasminogen Inactivators
Waist Circumference
Body Mass Index
Obesity
Cross-Sectional Studies
Regression Analysis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. / Qi, Qibin; Wang, Jing; Li, Huaixing; Yu, Zhijie; Ye, Xingwang; Hu, Frank B.; Franco, Oscar H.; Pan, An; Liu, Yong; Lin, Xu.

In: European Journal of Endocrinology, Vol. 159, No. 5, 11.2008, p. 585-593.

Research output: Contribution to journalArticle

Qi, Qibin ; Wang, Jing ; Li, Huaixing ; Yu, Zhijie ; Ye, Xingwang ; Hu, Frank B. ; Franco, Oscar H. ; Pan, An ; Liu, Yong ; Lin, Xu. / Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. In: European Journal of Endocrinology. 2008 ; Vol. 159, No. 5. pp. 585-593.
@article{b2fea257216b4e9599b6d62b23ef46ce,
title = "Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese",
abstract = "Objective: Resistin increases insulin resistance (IR) in mice. However, the role of resistin in human disease remains controversial. We aimed to assess plasma resistin levels and their associations with inflammatory and fibrinolytic markers, IR and metabolic syndrome (MetS) among Chinese. Design and methods: Plasma resistin was measured in a population-based cross-sectional survey of 3193 Chinese aged from 50 to 70 years in Beijing and Shanghai. Results: The median resistin concentration was 8.60 ng/ml (interquartile range, 5.78-14.00) among all participants, and it was higher in women than in men (P=0.008). Resistin was correlated weakly with body mass index, waist circumference, high-density lipoprotein (HDL) cholesterol (negatively), homeostatic model assessment of IR and tumor necrosis factor-α receptor 2 (TNFR2; r=0.04, 0.07, -0.09 and 0.06 respectively, all P <0.05), and more highly with C-reactive protein (CRP), interleukin (IL)6 and plasminogen activator inhibitor (PAI1 (r=0.12, 0.12 and 0.21 respectively, all P<0.001), but only HDL cholesterol, CRP, IL6, TNFR2, and PAI1 remained significantly associated with resistin in multiple regression analysis (all P <0.05). Furthermore, elevated resistin levels were associated with the higher prevalence of IR and MetS. However, the significant relationships disappeared after adjustment for inflammatory and fibrinolytic markers especially PAI1. Conclusions: This study suggests that resistin is more strongly associated with inflammatory and fibrinolytic markers than with obesity or IR status. The associations of resistin with IR and MetS could largely be explained by inflammatory and fibrinolytic markers especially PAI1 levels.",
author = "Qibin Qi and Jing Wang and Huaixing Li and Zhijie Yu and Xingwang Ye and Hu, {Frank B.} and Franco, {Oscar H.} and An Pan and Yong Liu and Xu Lin",
year = "2008",
month = "11",
doi = "10.1530/EJE-08-0427",
language = "English (US)",
volume = "159",
pages = "585--593",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "5",

}

TY - JOUR

T1 - Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese

AU - Qi, Qibin

AU - Wang, Jing

AU - Li, Huaixing

AU - Yu, Zhijie

AU - Ye, Xingwang

AU - Hu, Frank B.

AU - Franco, Oscar H.

AU - Pan, An

AU - Liu, Yong

AU - Lin, Xu

PY - 2008/11

Y1 - 2008/11

N2 - Objective: Resistin increases insulin resistance (IR) in mice. However, the role of resistin in human disease remains controversial. We aimed to assess plasma resistin levels and their associations with inflammatory and fibrinolytic markers, IR and metabolic syndrome (MetS) among Chinese. Design and methods: Plasma resistin was measured in a population-based cross-sectional survey of 3193 Chinese aged from 50 to 70 years in Beijing and Shanghai. Results: The median resistin concentration was 8.60 ng/ml (interquartile range, 5.78-14.00) among all participants, and it was higher in women than in men (P=0.008). Resistin was correlated weakly with body mass index, waist circumference, high-density lipoprotein (HDL) cholesterol (negatively), homeostatic model assessment of IR and tumor necrosis factor-α receptor 2 (TNFR2; r=0.04, 0.07, -0.09 and 0.06 respectively, all P <0.05), and more highly with C-reactive protein (CRP), interleukin (IL)6 and plasminogen activator inhibitor (PAI1 (r=0.12, 0.12 and 0.21 respectively, all P<0.001), but only HDL cholesterol, CRP, IL6, TNFR2, and PAI1 remained significantly associated with resistin in multiple regression analysis (all P <0.05). Furthermore, elevated resistin levels were associated with the higher prevalence of IR and MetS. However, the significant relationships disappeared after adjustment for inflammatory and fibrinolytic markers especially PAI1. Conclusions: This study suggests that resistin is more strongly associated with inflammatory and fibrinolytic markers than with obesity or IR status. The associations of resistin with IR and MetS could largely be explained by inflammatory and fibrinolytic markers especially PAI1 levels.

AB - Objective: Resistin increases insulin resistance (IR) in mice. However, the role of resistin in human disease remains controversial. We aimed to assess plasma resistin levels and their associations with inflammatory and fibrinolytic markers, IR and metabolic syndrome (MetS) among Chinese. Design and methods: Plasma resistin was measured in a population-based cross-sectional survey of 3193 Chinese aged from 50 to 70 years in Beijing and Shanghai. Results: The median resistin concentration was 8.60 ng/ml (interquartile range, 5.78-14.00) among all participants, and it was higher in women than in men (P=0.008). Resistin was correlated weakly with body mass index, waist circumference, high-density lipoprotein (HDL) cholesterol (negatively), homeostatic model assessment of IR and tumor necrosis factor-α receptor 2 (TNFR2; r=0.04, 0.07, -0.09 and 0.06 respectively, all P <0.05), and more highly with C-reactive protein (CRP), interleukin (IL)6 and plasminogen activator inhibitor (PAI1 (r=0.12, 0.12 and 0.21 respectively, all P<0.001), but only HDL cholesterol, CRP, IL6, TNFR2, and PAI1 remained significantly associated with resistin in multiple regression analysis (all P <0.05). Furthermore, elevated resistin levels were associated with the higher prevalence of IR and MetS. However, the significant relationships disappeared after adjustment for inflammatory and fibrinolytic markers especially PAI1. Conclusions: This study suggests that resistin is more strongly associated with inflammatory and fibrinolytic markers than with obesity or IR status. The associations of resistin with IR and MetS could largely be explained by inflammatory and fibrinolytic markers especially PAI1 levels.

UR - http://www.scopus.com/inward/record.url?scp=56749103005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749103005&partnerID=8YFLogxK

U2 - 10.1530/EJE-08-0427

DO - 10.1530/EJE-08-0427

M3 - Article

VL - 159

SP - 585

EP - 593

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 5

ER -